Related Experiment Videos
[Effect of pentazocine administration on MHV3 virus experimental hepatitis in mice]
Abstract:
Mice treated with 15mg/kg/day pentazocin and infected with MHV-3 virus after 7 days did not show increased susceptibility to MHV-3 virus infection, did not develop more serious forms of hepatitis and mortality did not increase with respect to the controls. Drug administration was continued for the duration of the experiment.
Insights
Pentazocine treatment did not increase mouse susceptibility to MHV-3 virus infection or hepatitis severity. Mortality rates remained unchanged in pentazocine-treated mice compared to controls, indicating no adverse effects on viral hepatitis outcomes.
Area of Science:
- Virology
- Immunology
- Pharmacology
Context:
- Murine hepatitis virus (MHV-3) is a significant pathogen in mouse models.
- Investigating the impact of analgesic drugs on viral infections is crucial for patient care.
- Pentazocine is a commonly used opioid analgesic.
Purpose:
- To determine if pentazocine administration affects susceptibility to MHV-3 infection.
- To assess the influence of pentazocine on the severity of MHV-3-induced hepatitis.
- To evaluate the effect of pentazocine on mortality rates in MHV-3 infected mice.
Summary:
- Mice received pentazocine (15mg/kg/day) for seven days prior to MHV-3 virus infection.
- Post-infection, treated mice showed no increased susceptibility to MHV-3.
- No exacerbation of hepatitis or increased mortality was observed in the pentazocine group compared to controls.
Impact:
- Pentazocine does not appear to negatively impact the course of MHV-3 infection in mice.
- Findings suggest pentazocine can be safely administered to mice during MHV-3 infection.
- This study provides foundational data for further research into drug-virus interactions.